Clinical Trial

Disease: Human Immunodeficiency Virus Infection, HIV, (NCT02388594)

Disease info:

Human immunodeficiency virus (HIV) is a virus that attacks the immune system by infecting and killing white blood cells known as CD4+ T-cells. CD4+ T-cells represent a vital part of the immune system and untreated HIV infections render patients more vulnerable to dangerous infections by other pathogens, including bacteria and fungi. If the virus remains untreated it can lead to patients developing the life-threatening disease acquired immunodeficiency syndrome (AIDS). Untreated HIV can leave people vulnerable to life-threatening infections. HIV symptoms often manifest as flu-like symptoms such as fever, chills, rash, night sweats, muscle aches, sore throat, and fatigue. Today, antiviral medications can allow people living with HIV to live healthy lives.

 

Indicator
IND Enabling Pre-clinical
Phase I Safety
Phase II Safety and Dosing
Phase III Safety and Efficacy
Dec. 28, 2023

Unlock Premium CMN Content Today with a CMN+ Subscription

Already a CMN+ subscriber? Log in here

logo
Subscribe now

Subscribe to CMN+ and get access to premium CMN Content, CRISPRMED Recordings, Clinical Trial Database, Special offers ....

close
Search CRISPR Medicine